The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Sokolov D.A.
Yaroslavl State Medical University;
Regional Clinical Hospital
Zhbannikov P.S.
Yaroslavl State Medical University
Ganert A.N.
Yaroslavl State Medical University;
Regional Clinical Hospital
Lyuboshevskiy P.A.
Yaroslavl State Medical University;
Regional Clinical Hospital
Accuracy of predictors of perioperative cardiovascular complications in onco-surgery
Journal: Russian Journal of Anesthesiology and Reanimatology. 2023;(3): 37‑44
Views: 2393
Downloaded: 169
To cite this article:
Sokolov DA, Zhbannikov PS, Ganert AN, Larionov SV, Lyuboshevskiy PA. Accuracy of predictors of perioperative cardiovascular complications in onco-surgery. Russian Journal of Anesthesiology and Reanimatology.
2023;(3):37‑44. (In Russ., In Engl.)
https://doi.org/10.17116/anaesthesiology202303137
To assess the informative value of predictors of potential perioperative cardiovascular complications (CVC) in oncological abdominal surgery.
We examined 114 patients aged 67 [61—72] years who underwent elective oncological surgery. Perioperative CVCs were recorded. We analyzed prognostic significance of patient characteristics (including calculated cardiac risk indices — CRI) and biomarkers in relation to CVC.
Perioperative CVCs occurred in 13 (11.4%) patients. According to logistic regression, predictors of perioperative CVC were CRI Khoronenko (p=0.0001) and CRI MICA (p=0.0023). AUC for these indices was 0.774 and 0.798, respectively. Preoperative serum NT-proBNP demonstrated higher quality of predictive model: OR 1.0112; 95% CI 1.0054—1.0170; p=0.0001; AUC 0.91. Serum biomarker >257 pg/ml discriminated patients with perioperative CVC with a sensitivity of 84.62% and specificity of 86.17%.
Preoperative serum NT-proBNP >257 pg/mL with sensitivity and specificity >80% is a predictor of perioperative CVC after abdominal oncological surgery. Assessment of this marker is appropriate in patients with high and intermediate cardiac risk.
Keywords:
Authors:
Sokolov D.A.
Yaroslavl State Medical University;
Regional Clinical Hospital
Zhbannikov P.S.
Yaroslavl State Medical University
Ganert A.N.
Yaroslavl State Medical University;
Regional Clinical Hospital
Lyuboshevskiy P.A.
Yaroslavl State Medical University;
Regional Clinical Hospital
Received:
07.02.2023
Accepted:
17.03.2023
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.